Investments in Research

Georgia CORE has developed and nurtured collaboration with other organizations working to fight cancer which has enabled us to further our dollars and increase the impact on advancements in cancer research.

Georgia Cancer Research Fund

The Georgia Cancer Research Fund is administered by Georgia CORE and funded by Georgia taxpayers who elect to donate on their tax forms. Monies from the fund are currently going to the “Collaborative Institutions Seed Grant Program for Cancer Research.” The grant provides seed funding for a cancer research project that involves two or more institutions or organizations in the state of Georgia comprised of a lead and a collaborative research entity. 

• In November 2023, Georgia CORE released an RFP for the 3rd annual Collaborative Cancer Research Seed Grant.
• For the FY25 grant cycle, the focus is impacting cancer morbidity or mortality rates.
• Letters of Intent are due Dec. 20, 2023 and full grant proposals are due Feb. 28, 2024.

See past grantees and how you can contribute to the fund here.

Publications

Georgia CORE staff and board members regularly contribute to a number of research publications, some of which are listed on this site, including a 2023 article on Racial disparity in breast cancer survivorship as well as a 2018 article in the The Journal of Clinical Oncology which features the first ten years of Georgia CORE's research network and our focus on clinical trials.

Gynecologic Oncology Group Consortium to NRG Oncology to NCORP

The Georgia CORE Gynecologic Oncology Group Consortium was created in 2007 as a unique, collaborative model to provide access to National Cancer Institute-sponsored gynecologic clinical trials by affiliated gynecologic oncologists throughout the state. Since its inception, the Consortium has enrolled more than 225 patients on clinical trials, roughly one-quarter of whom are racial/ethnic minorities. This Consortium became a full member of the Gynecologic Oncology Group (GOG) in 2009 after two years of provisional membership. The Georgia CORE GOG Consortium has demonstrated the effectiveness of this innovative approach in several critical areas: growth of academic and community-based affiliates; volume of enrollment on GOG studies; enrollment of minority and rural patients; quality of data as determined by monitoring and auditing; participation in high priority and Phase I studies; and leadership on national GOG committees. In 2013, nine organizations were affiliated with the Georgia CORE GOG Consortium. During that year, the Consortium acquired nearly four times the required number of membership points.

In 2014, NCI's GOG transitioned into NRG Oncology; Georgia CORE became a main voting member of NRG Oncology, and then a partner in Georgia NCORP.

Last Updated: 11/29/2023 1:27:54 PM